| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3 ABCD
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF10 (in situ hybridization)
|
|
|
|
Fig. 7 C
Sullivan CH et al. (2019)
|
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization)
|
|
|
|
Fig 7 ADGJM (c1)
Deimling SJ and Drysdale TA (2011)
|
Xla Wt + Retinoic acid
NF18-20 (in situ hybridization)
|
|
|
|
|
Fig. 7 CFILO
Deimling SJ and Drysdale TA (2011)
|
Xla Wt + retinol
NF18-20 (in situ hybridization)
|
|
|
|
fig.1.p
Cao Y et al. (2006)
|
Xla Wt + Mmu.Pou5f1
NF11.5 (RT-PCR)
|
|
|
|
|
fig.1.p
Cao Y et al. (2006)
|
Xla Wt + pou5f3.2
NF11.5 (RT-PCR)
|
|
|
|
|
fig.1.p
Cao Y et al. (2006)
|
Xla Wt + pou5f3.3
NF11.5 (RT-PCR)
|
|
|
|
B
Shimizu-Nishikawa K et al. (2003)
|
Xla Wt + hindlimb amputation
NF54 (in situ hybridization)
|
|
|
|
a, d
Yokoyama H et al. (2001)
|
Xla Wt + Hsa.FGF10 + hindlimb amputation
NF58 (in situ hybridization)
|
|
|
|
Fig 3. A,B
Yokoyama H et al. (1998)
|
Xla Wt + hindlimb amputation
NF65 (stained tissue microscopy)
|
|
|